JPH0717847A - Skin external preparation - Google Patents

Skin external preparation

Info

Publication number
JPH0717847A
JPH0717847A JP5162515A JP16251593A JPH0717847A JP H0717847 A JPH0717847 A JP H0717847A JP 5162515 A JP5162515 A JP 5162515A JP 16251593 A JP16251593 A JP 16251593A JP H0717847 A JPH0717847 A JP H0717847A
Authority
JP
Japan
Prior art keywords
extract
kojic acid
external preparation
acid
plant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5162515A
Other languages
Japanese (ja)
Other versions
JP3529811B2 (en
Inventor
Shinsuke Honda
伸介 本多
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sansho Pharmaceutical Co Ltd
Original Assignee
Sansho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sansho Pharmaceutical Co Ltd filed Critical Sansho Pharmaceutical Co Ltd
Priority to JP16251593A priority Critical patent/JP3529811B2/en
Publication of JPH0717847A publication Critical patent/JPH0717847A/en
Application granted granted Critical
Publication of JP3529811B2 publication Critical patent/JP3529811B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To provide a skin external preparation synergistically raised in active oxygen-scavenging activity, excellent in effect of preventing wrinkles induced by UV-A radiation, containing a combination of kojic acid and/or its derivative with specific plant extract(s). CONSTITUTION:The skin external preparation containing, as active ingredients, (A) kojic acid and/or a derivative therefrom and (B) at least one kind of extract of plant(s) selected from a group composed of Acacia catechu, Hydrangea serrata, Scutellaria baicalensis, Cinchona succirubra, Potentilla fragarioides L., cucumber, clover, black tea, Betula platyphylla scrub, water melon, stevia, Hedera helix, Thymus vulgaris L., Eugenia caryophyllata, Oenothera tetraptera, Sorbus commixta, banana, Isodon japonicus, Hayflower, Marsh tea, Ilex paraguayensis, melon, apple, lavender, and lemon.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、コウジ酸及び/又はコ
ウジ酸誘導体と特定の植物のエキスを有効成分として含
有することを特徴とする皮膚外用剤に関するものであっ
て、より詳しくは、特定の植物のエキスを併用すること
によってコウジ酸又はその誘導体の活性酸素消去作用を
相乗的に高め、UV−Aで誘引されるシワの防止効果に
優れた皮膚外用剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an external preparation for skin characterized by containing kojic acid and / or kojic acid derivative and an extract of a specific plant as an active ingredient. The present invention relates to a skin external preparation having an excellent effect of preventing UV-A-induced wrinkles by synergistically enhancing the active oxygen scavenging action of kojic acid or its derivative by using the plant extract of the above.

【0002】[0002]

【従来の技術】活性酸素は、酸素分子が生体内で還元さ
れた、スーパーオキサイド、過酸化水素、ヒドロキシラ
ジカルを経て水になる過程で生成する。活性酸素は、生
体膜や組織に傷害を引き起こし、種々の疾病の原因とな
ることが知られている。皮膚の炎症や老化も活性酸素が
もたらす組織傷害の中の一つであり、太陽、とりわけ紫
外線がもたらす悪影響とならんで、近年老化メカニズム
解明の鍵を握るものとして研究がさかんに行われてい
る。
2. Description of the Related Art Active oxygen is produced in the process in which oxygen molecules are reduced in a living body to become water through superoxide, hydrogen peroxide and hydroxyl radicals. It is known that active oxygen causes damage to biological membranes and tissues and causes various diseases. Skin inflammation and aging are also one of the tissue injuries caused by active oxygen, and along with the adverse effects of the sun, especially ultraviolet rays, research has been extensively conducted in recent years as a key to elucidating the aging mechanism.

【0003】皮膚の老化は、加齢によって進行し、紫外
線等の外の因子によって加速されることが知られてい
る。紫外線にはその波長領域によって、UV−A(32
0ないし400nm)、UV−B(280ないし320
nm)、UV−C(200ないし280nm)に大別さ
れるが、真皮にまで達しシワを誘引すると考えられるの
はUV−A領域の紫外線である。この皮膚の老化に深く
関係のある外の要因に加え、内の要因として注目されて
きたのが、活性酸素である。
It is known that skin aging progresses with aging and is accelerated by external factors such as ultraviolet rays. UV-A (32
0 to 400 nm), UV-B (280 to 320)
nm) and UV-C (200 to 280 nm), but it is ultraviolet rays in the UV-A region that are thought to reach the dermis and induce wrinkles. In addition to the external factors closely related to skin aging, active oxygen has been attracting attention as an internal factor.

【0004】コウジ酸は色素剤として公知である(例え
ば特公昭56−18569号公報、特公昭61−104
47号公報など)が、一方ではラジカルスカベンジャー
を有することも知られている。しかしながら、コウジ酸
の活性酸素消去作用はそれ程強くないため、さらに効果
の強い実用性の高いものが求められていた。
Kojic acid is known as a coloring agent (for example, JP-B-56-18569 and JP-B-61-104).
47), but on the other hand, it is also known to have a radical scavenger. However, the action of scavenging active oxygen of kojic acid is not so strong, and therefore a highly effective and highly practical one has been demanded.

【0005】[0005]

【発明が解決しようとする課題】本発明は、特定の植物
のエキスを併用することによって、コウジ酸又はその酸
誘導体の活性消去作用を相乗的に高め、UV−A等によ
って誘引されるシワを防止する効果に優れた新規な皮膚
外用剤を提供することを目的とするものである。
The present invention synergistically enhances the activity scavenging action of kojic acid or its acid derivative by using an extract of a specific plant in combination, and suppresses wrinkles induced by UV-A or the like. It is an object of the present invention to provide a new external preparation for skin which is excellent in preventing effect.

【0006】[0006]

【課題を解決するための手段】本発明者らは、前記目的
を達成するために鋭意研究を重ねてきた結果、アセンヤ
ク、アマチャ、オウゴン、キナ、キジムシロ、キューカ
ンバー、クローバー、紅茶、白樺幹スクラブ、スイカ、
ステビア、セイヨウキズタ、タチジャコソウ、チョウ
ジ、月見草、ナナカマド、バナナ、ヒキオコシ、ヘイフ
ラワー、マーシュティー、マテ、メロン、リンゴ、ラベ
ンダー、レモンからなる群より選ばれた植物のエキスの
一種又は二種以上をコウジ酸及び/又はその誘導体に併
用することによって、それらの薬理特性である活性酸素
消去作用が相乗的に高められることを見出し、本発明を
完成した。すなわち、本発明によれば、コウジ酸及び/
又はその誘導体と、前記特定の植物のエキスを有効成分
として含有することを特徴とする老化防止効果に優れた
皮膚外用剤が提供される。
Means for Solving the Problems As a result of intensive studies to achieve the above-mentioned objects, the present inventors have found that Acenyak, Amacha, Ougon, Kina, Kizimushiro, Cucumber, Clover, Black Tea, Shirakaba Stem Scrub, watermelon,
One or more kinds of plant extracts selected from the group consisting of stevia, hollyhock, oleander, clove, evening primrose, rowan, banana, hikoshi, hayflower, marsh tea, mate, melon, apple, lavender, lemon. The present invention has been completed by finding that their combined use with an acid and / or its derivative synergistically enhances their pharmacological properties, active oxygen scavenging action. That is, according to the present invention, kojic acid and / or
Alternatively, there is provided a skin external preparation having an excellent anti-aging effect, which comprises a derivative thereof and an extract of the specific plant as an active ingredient.

【0007】[0007]

【発明の具体的説明】本発明において使用されるコウジ
酸(5−オキシ−2−オキシメチル−γ−ピロン)とし
ては、5−オキシ−2−オキシメチル−γ−ピロンの純
品、コウジ酸生産能を有する公知の菌株を培養して得ら
れるコウジ酸を主成分とする醗酵液、該醗酵液の濃縮
液、及び該醗酵液からコウジ酸を抽出して結晶化したも
のなどが使用される。
Detailed Description of the Invention Kojic acid (5-oxy-2-oxymethyl-γ-pyrone) used in the present invention is a pure product of 5-oxy-2-oxymethyl-γ-pyrone, kojic acid. A fermentation broth containing kojic acid as a main component obtained by culturing a known strain having productivity, a concentrated solution of the fermentation broth, and a crystallized extract of kojic acid from the fermentation broth are used. .

【0008】コウジ酸誘導体としては、例えば、特公昭
60−10005号公報、特公平1−45472号公
報、特公平3−74229号公報、特公昭58−221
51号、特公昭58−22152号公報に開示されてい
るコウジ酸のエステル化物及びコウジ酸の2位の−CH
2 OH基に糖類を結合させることによって、コウジ酸分
子を安定化させたコウジ酸誘導体等公知のものを単独又
は二種以上を組み合わせて用いることができる。
Examples of the kojic acid derivative include, for example, Japanese Patent Publication No. 60-10005, Japanese Patent Publication No. 1-45472, Japanese Patent Publication No. 3-74229, and Japanese Patent Publication No. 58-221.
No. 51, Japanese Patent Publication No. 58-22152, an esterification product of kojic acid and -CH at the 2-position of kojic acid.
Known compounds such as a kojic acid derivative in which a kojic acid molecule is stabilized by binding a saccharide to the 2 OH group can be used alone or in combination of two or more kinds.

【0009】コウジ酸及び/又はその酸誘導体と併用す
る特定の植物のエキスとしては、以下のものが例示でき
る。
Specific examples of plant extracts used in combination with kojic acid and / or its acid derivatives include the following.

【0010】アセンヤク(Uncaria gambir Roxburgh(Ru
biaceae))は、マレー原産で、ジャワ、スマトラ、ボル
ネオなどで栽培される。そのエキス(Gambir Extract)
としては、葉及び若枝から1,3−ブチレングリコール
溶液またはエタノール溶液で抽出して得られるエキスが
好適に使用できる。
Uncaria gambir Roxburgh (Ru
biaceae)) is native to Malay and is cultivated in Java, Sumatra, Borneo, etc. Gambir Extract
As the extract, an extract obtained by extracting from leaves and young shoots with a 1,3-butylene glycol solution or an ethanol solution can be preferably used.

【0011】アマチャエキス(Hydrangea Extract )と
しては、アマチャ(Hydrangea serrata Seringe var. t
hunbergii Sugimoto)の葉及び枝先を精製水、エタノー
ルあるいはこれらの混液を加えて冷浸または温浸して得
られるエキス、あるいはエキスを乾燥させ粉末にしたも
のが好適に使用できる。
As the armature extract (Hydrangea Extract), the armature (Hydrangea serrata Seringe var.
(Hungerberg sugimoto) leaves and branch tips are added with purified water, ethanol or a mixed solution thereof, and the extract is obtained by cold or hot digestion, or a powder obtained by drying the extract is preferably used.

【0012】オウゴン(Scutellaria baicalensis Geor
gi(Labiatae))は中国産で、別名をコガネバナともい
い、漢方では充血をとるのに用いられてきた。そのエキ
ス(Scutellaris Root Extract)としては、コガネバナ
の周皮を除いた根を精製し、エタノール又はこれらの混
液にて抽出したエキスで、1,3−ブチレングリコール
またはエタノールと混和したものが好適に使用できる。
Scutellaria baicalensis Geor
gi (Labiatae)) is from China, and is also known as Scutellaria baicalensis, and it has been used in Chinese medicine to eliminate hyperemia. As the extract (Scutellaris Root Extract), the roots of Scutellaria baicalensis excluding the pericarp are purified and extracted with ethanol or a mixture thereof, which is preferably mixed with 1,3-butylene glycol or ethanol. it can.

【0013】キナ(Cinchona)属の植物は、ペルー、ポ
リビア、エクアドルにわたるアンデス山中に野生してい
て、その種類は400種以上に及ぶ。キナエキス(Cinc
honaExtract)としては、キナ(Cinchona succirubra P
avon et Klotzch(Rubiaceae) )または、そのほか同属
植物の樹皮より精製水、プロピレングリコール、エタノ
ール、またはこれらの混液にて抽出して得られるエキス
が好適に使用できる。
The plants of the genus Cinchona are wild in the Andes Mountains in Peru, Polyvia and Ecuador, and there are more than 400 species. Quina extract (Cinc
As honaExtract, Kina (Cinchona succirubra P
avon et Klotzch (Rubiaceae)) or other extract obtained by extracting from the bark of a plant of the same genus with purified water, propylene glycol, ethanol, or a mixture thereof.

【0014】キジムシロ(Potentillae anserinae )
は、通常湿った粘土質土壌に成育し、長い枝と銀白色の
毛が密生した多くの羽状の葉を持つ植物で、長い果柄の
ない明黄色の花が咲く。そのエキス(Potentilla Extra
ct)としては、葉の抽出物が好適に使用できる。
Potentillae anserinae
Is a plant with many pinnate leaves, usually grown in moist clay soils, with long branches and dense silvery-haired hair, with long, fruitless bright yellow flowers. The extract (Potentilla Extra
As ct), leaf extract can be preferably used.

【0015】キューカンバーエキス(Cucumber Extrac
t)としては、キュウリ(Cucumis sativus )の果実を
圧搾して得た果実、又は果実を精製水または1,3−ブ
チレングリコール、プロピレングリコール、またはこれ
らの混液にて抽出して得られるエキスに濃グリセリンを
加えたものが好適に使用できる。
Cucumber Extrac
t) is a fruit obtained by squeezing the fruit of cucumber (Cucumis sativus), or concentrated in an extract obtained by extracting the fruit with purified water or 1,3-butylene glycol, propylene glycol, or a mixture thereof. What added glycerin can be used conveniently.

【0016】クローバー(Trifolium pratense)は15
ないし50cmの高さになるマメ科の多年草で、葉は三
葉からなる。花は白い丸い形をしていて、蜜を多く含
む。そのエキス(Clover Blossom Extract)としては、
花から抽出されるものが好適に使用できる。
Clover (Trifolium pratense) has 15
It is a legume perennial that grows up to 50 cm in height and has three leaves. The flowers have a white round shape and are rich in nectar. As the extract (Clover Blossom Extract),
Those extracted from flowers can be preferably used.

【0017】紅茶エキス(Fermented Tea Extract )と
しては、アッサムチャ(TeasinesisL.var assamica Pie
rre(Theaceae:ツバキ科) )の葉をわずかに乾燥した
後、醗酵させ、さらに乾燥し、細切したものをエタノー
ル溶液で抽出して得たエキスが好適に使用できる。
As the tea extract (Fermented Tea Extract), there is Assamcha (Teasinesis L. var assamica Pie
An extract obtained by slightly drying leaves of rre (Theaceae: Camelliaceae)), fermenting, further drying, and extracting the minced ones with an ethanol solution can be suitably used.

【0018】シラカバ(バーチ)(Betula alba L.,Bet
ula leuta L.,Folia betula )はカバノキ科の植物で、
北半球の温帯北部に広く分布する。そのエキス(Birch
Extract,Birch Leaf Extract,Birch Bark Extract )と
しては、葉、樹皮、木部から精製水、エタノール、プロ
ピレングリコール、1,3−ブチレングリコールなどで
抽出したエキスが好適に使用できる。また、その油溶性
エキスとしては、樹皮からエタノール抽出物をスクワラ
ンで抽出したエキスが好適に使用できる。
Birch (Betula alba L., Bet)
ula leuta L., Folia betula) is a plant of the birch family,
Widely distributed in the northern temperate zone of the Northern Hemisphere. The extract (Birch
Extracts, Birch Leaf Extracts, Birch Bark Extracts) are preferably extracts extracted from leaves, bark and xylem with purified water, ethanol, propylene glycol, 1,3-butylene glycol and the like. Further, as the oil-soluble extract, an extract obtained by extracting an ethanol extract from bark with squalane can be preferably used.

【0019】スイカ(Citrullus battich Forsk )は、
ウリ科の1年生つる性草本である。そのエキスとして
は、果実または種子より抽出したものが好適に使用でき
る。
Watermelon (Citrullus battich Forsk) is
It is a first-year climbing herb of the Cucurbitaceae family. As the extract, those extracted from fruits or seeds can be preferably used.

【0020】ステビア(Stevia rebandiona Bertoni )
は、南米原産のキク科の多年草である。そのエキスとし
ては、全草より抽出したものが好適に使用できる。
Stevia (Stevia rebandiona Bertoni)
Is an Asteraceae perennial native to South America. As the extract, one extracted from whole grass can be preferably used.

【0021】セイヨウキズタ(Hedera helix)はウコギ
科の多年生植物で、樹や壁に伸びる弦性の常緑の低木で
ある。ヨーロッパからコーカサス地方に原産するそのエ
キス(Ivy Extract )としては、茎及び葉からプロピレ
ングリコール、1,3−ブチレングリコールおよびこれ
らの水溶液で抽出したものが好適に使用できる。
Hedera helix is a perennial plant of the family Araliaceae, which is a stringy evergreen shrub that grows on trees and walls. As the extract (Ivy Extract) originating from Europe in the Caucasus region, propylene glycol, 1,3-butylene glycol extracted from stems and leaves and those extracted with an aqueous solution thereof can be preferably used.

【0022】タチジャコソウ(Thymus vulgaris L.)は
南ヨーロッパに生育する低木で、40cmの高さにな
り、灰緑色のだ円型の葉を持つ、花は小さく淡赤色ある
いは青紫色である。そのエキス(Thyme Extract )とし
ては、全草からプロピレングリコール、ブチレングリコ
ールまたはこれらの水溶液で抽出して得られる抽出物が
好適に使用できる。
Thymus vulgaris L. is a shrub that grows in southern Europe, is 40 cm in height, has oval-shaped leaves of gray-green, and has small, pale red or bluish purple flowers. As the extract (Thyme Extract), an extract obtained by extracting propylene glycol, butylene glycol or an aqueous solution thereof from whole grass can be preferably used.

【0023】チョウジ(Syzygium aromaticum Merrill
et Perry,Eugenia caryophyllata Thunberg )はモルッ
カ群島原産、スマトラ、ジャワ、アンボン、マダガスカ
ル、ザンジバル、西インド諸島などで栽培されている、
フトモモ科の常緑高木である。そのエキス(Clove Extr
act )としては、つぼみから得られたものが好適に使用
できる。
Clove (Syzygium aromaticum Merrill
et Perry, Eugenia caryophyllata Thunberg) is native to the Moluccas, Sumatra, Java, Ambon, Madagascar, Zanzibar, West Indies, etc.,
It is an evergreen tree in the family Amphitaceae. The extract (Clove Extr
As act), those obtained from buds can be preferably used.

【0024】月見草(Oenothera tertraptera Cav.Oeno
thera hookeri )は、細い茎、ひだ状の黄色花を持ち、
1mの高さまで成長する植物で、ヨーロッパ、アメリカ
のおもに乾燥した丘陵地帯に生育する。そのエキス(Ev
ening Primrose Extract)としては、全草から抽出され
たものが好適に使用できる。
[Evening Primrose (Oenothera tertraptera Cav.Oeno
thera hookeri) has thin stems, folds of yellow flowers,
A plant that grows up to a height of 1 m, it grows mainly in the dry hills of Europe and America. The extract (Ev
As the ening Primrose Extract), those extracted from whole grass can be preferably used.

【0025】ナナカマド(Sorbus aucuparia)は落葉樹
で、おもにヨーロッパ一帯で見られる。複葉をもち、葉
の裏側に毛が密生している。花は白く傘のような形をし
ており、明赤色の漿果が実る。そのエキス(Mountain A
sh Extract)としては、実の抽出物が好適に使用でき
る。
Rowan (Sorbus aucuparia) is a deciduous tree and is found mainly in Europe. It has compound leaves, and the hair is dense on the back side of the leaves. The flowers are white and shaped like an umbrella, with bright red berries. The extract (Mountain A
As the sh Extract), a fruit extract can be preferably used.

【0026】バナナ(Musa sapientum)は、多年草の植
物で、多くの熱帯及び亜熱帯の国々で栽培されている。
そのエキス(Banana Extract)としては、実の抽出物が
好適に使用できる。
Banana (Musa sapientum) is a perennial plant that is cultivated in many tropical and subtropical countries.
As the extract (Banana Extract), a fruit extract can be preferably used.

【0027】ヒキオコシ(Isodon japonicus Hara )は
シソ科の植物で、北海道南部以南の日本各地、朝鮮等に
自生する多年草である。クロバナヒキオコシ(Isodon t
richocarpus Kubo)は、本州福井以東、北海道の山地に
群生している。両種とも全草を乾燥して延命草(Isodon
is Herba)とよばれる。そのエキス(Isodonis HerbaEx
tract)としては、茎葉からエタノール、精製水、1,
3−ブチレングリコールなどで抽出して得られるエキ
ス、または酢酸エチル抽出した後、酢酸エチルを留去
後、エタノールまたは精製水を加えたものが好適に使用
できる。
Hikiokoshi (Isodon japonicus Hara) is a plant of the Lamiaceae family and is a perennial plant that grows naturally in various parts of Japan, such as south of southern Hokkaido and Korea. Black squirrel (Isodon t
richocarpus Kubo) grows in the mountains of Hokkaido, east of Fukui, Honshu. Both species are dried whole plants and
is Herba). The extract (Isodonis HerbaEx
tract), foliage from ethanol, purified water, 1,
An extract obtained by extraction with 3-butylene glycol or the like, or an extract obtained by extracting with ethyl acetate, distilling off ethyl acetate and then adding ethanol or purified water can be preferably used.

【0028】ヘイフラワーエキス(Hayflower Extract
)としては、ヘイフラワー(Graminis)の花が好適に
使用できる。
Hayflower Extract
As the), flowers of hay flower (Graminis) can be preferably used.

【0029】マーシュティー(Ledi polustris)は、
北、東ヨーロッパ、北アジア、北米の沼地または湿地で
よく見うけられる常緑低木で、散開した枝、かたい披針
状の葉、白またはピンク色の繖形花をもつ。そのエキス
(Marsh Tea Extract )としては、葉から得られたもの
が好適に使用できる。
Marsh tea (Ledi polustris)
An evergreen shrub commonly found in marshes or wetlands in northern, eastern Europe, northern Asia, and North America, with open branches, hard lanceolate leaves, and white or pink vermicular flowers. As the extract (Marsh Tea Extract), those obtained from leaves can be preferably used.

【0030】マテ(Ilex peraguariensis )は、野生で
は低木であるが、時には、20mにも達する高さになる
ものもある。互生葉で、葉腋に白い花が集まって咲く。
果実は、小さな黒紫色の多肉果で4つの種子をもつ。そ
のエキス(Mate Extract)としては、葉から抽出された
ものが好適に使用できる。
Mate (Ilex peraguariensis) is a shrub in the wild, but sometimes it reaches a height of 20 m. Alternate leaves, white flowers gather on the axils and bloom.
The fruit is a small black-purple succulent fruit with four seeds. As the extract (Mate Extract), those extracted from leaves can be preferably used.

【0031】メロン(Cucumis melo L. )は、ウリ科の
つる性1年草で、そのエキス(Melon Extract )として
は、果実及び種子より抽出されたものが好適に使用でき
る。
[0031] Melon (Cucumis melo L.) is an annual herbaceous plant of the family Cucurbitaceae, and as the extract (Melon Extract), those extracted from fruits and seeds can be preferably used.

【0032】リンゴ(Pyrus malus L.)はバラ科の植物
で、広く各地に栽培される落葉喬木である。そのエキス
(Apple Extract )としては、果実を圧搾して得られる
液を濃縮し、濃グリセリンを加えたもの、あるいは果実
から1,3−ブチレングリコール、プロピレングリコー
ルで抽出して得られるエキスが好適に使用できる。
Apple (Pyrus malus L.) is a plant of the family Rosaceae, which is a deciduous tree cultivated in various places. As the extract (Apple Extract), a liquid obtained by squeezing the fruit and concentrating the liquid, or concentrated glycerin, or an extract obtained by extracting from the fruit with 1,3-butylene glycol or propylene glycol is preferable. Can be used.

【0033】ラベンダー(Lavandula officinalis )は
半潅木で、地中海西部、ダルマティア、ギリシャ原産
で、現在は南フランス、イギリス、イタリア、ハンガリ
ー、スペイン、北アフリカで栽培されている。綿状もし
くは槍形の青緑色の葉をもち、独特の匂いのする紫色の
花が咲く、そのエキス(Lavender Extract)としては、
花からの抽出物が好適に使用できる。
Lavandula officinalis is a semi-shrub, native to the western Mediterranean, Dalmatia and Greece, and currently cultivated in southern France, England, Italy, Hungary, Spain and North Africa. It has cotton-like or spear-shaped blue-green leaves, and purple flowers with a unique smell bloom. As an extract (Lavender Extract),
Extracts from flowers can be preferably used.

【0034】レモン(Citrus limon Burmann fil. )は
インドのヒマラヤ西部の山麓が原産であるが、現在、ア
メリカとイタリアが主産地である。そのエキス(Lemon
Extract )としては、果実を精製水、グリセリン、1,
3−ブチレングリコール、プロピレングリコールなどで
浸出し、または圧搾して得られるエキスまたは圧搾ろ過
して得られる果汁を濃縮後、濃グリセリンを加えたもの
が好適に使用できる。
Lemon (Citrus limon Burmann fil.) Originates from the foothills of the western Himalayas of India, but is currently mainly produced in the United States and Italy. The extract (Lemon
Extract), the fruit is purified water, glycerin, 1,
An extract obtained by leaching with or squeezing with 3-butylene glycol, propylene glycol or the like or a fruit juice obtained by squeezing and filtering and then adding concentrated glycerin can be preferably used.

【0035】本発明において、前記コウジ酸及び/又は
その誘導体と植物のエキスの配合量は、クリーム、ロー
ション、乳液、パック、化粧水、エッセンス等の化粧料
の場合と、軟膏剤、パップ剤、プラスター剤等の外用剤
として使用する場合のいずれにおいても、製剤全体に対
して、植物抽出エキスが0.0001ないし20重量
%、好ましくは0.01ないし10重量%、コウジ酸及
び/又はその誘導体が0.001ないし10重量%、好
ましくは0.1ないし5重量%の範囲で配合される。
In the present invention, the amount of the kojic acid and / or its derivative and the plant extract compounded is such that creams, lotions, milky lotions, packs, lotions, essences and other cosmetics, ointments and poultices are used. In any case of using it as an external preparation such as plaster, 0.0001 to 20% by weight, preferably 0.01 to 10% by weight, of a plant extract extract, kojic acid and / or its derivative relative to the whole preparation Is blended in the range of 0.001 to 10% by weight, preferably 0.1 to 5% by weight.

【0036】本発明の皮膚外用剤は、外用施用上適する
ものであれば特に制限はなく、先に挙げた用に、例えば
パップ剤、プラスター剤、ペースト剤、クリーム、軟
膏、エアゾ−ル剤、乳剤、ローション、乳液、エッセン
ス、パック、ゲル剤、パウダー、ファンデーション、サ
ンケア、バスソルトなどの医薬品、医薬部外品、化粧品
として公知の形態で幅広く使用に供されるものである。
The external preparation for skin of the present invention is not particularly limited as long as it is suitable for external application, and examples thereof include poultices, plasters, pastes, creams, ointments and aerosols, as mentioned above. It is widely used in the form known as pharmaceuticals such as emulsions, lotions, emulsions, essences, packs, gels, powders, foundations, sun care and bath salts, quasi drugs, and cosmetics.

【0037】本発明の外用剤を製する場合、通常に用い
られる種々の公知の有効成分、例えば塩化カルプロニウ
ム、セファランチン、ビタミンE、ビタミンEニコチネ
ート、ニコチン酸、ニコチン酸アミド、ニコチン酸ベン
ジル、ショウキョウチンキ、トウガラシチンキなどの清
涼剤、ヒノキチオール、塩化ベンザルコニウム、ウンデ
シレン酸などの抗菌剤、塩化リゾチーム、グリチルリチ
ン、アラントインなどの消炎剤、アスコルビン酸、アル
ブチンなどの色白剤、胎盤抽出液、肝臓抽出物、乳酸菌
培養抽出物等の動物・植物・微生物由来の各種抽出物な
どを適宜添加して使用することができる。
In the case of producing the external preparation of the present invention, various known active ingredients usually used, for example, carpronium chloride, cepharanthin, vitamin E, vitamin E nicotinate, nicotinic acid, nicotinic acid amide, benzyl nicotinate, and ginger. Cooling agents such as tincture, capsicum tincture, antibacterial agents such as hinokitiol, benzalkonium chloride, undecylenic acid, antiphlogistics such as lysozyme chloride, glycyrrhizin and allantoin, whitening agents such as ascorbic acid and arbutin, placenta extract, liver extract Various extracts derived from animals, plants and microorganisms such as lactic acid bacterium culture extracts can be appropriately added and used.

【0038】また、前述の医薬品、医薬部外品、化粧品
には公知の有効成分や界面活性剤、油脂類等の基剤成分
の他、必要に応じて公知の保湿剤、酸化防止剤、紫外線
吸収剤・散乱剤、キレート剤、pH調整剤、香料、着色
剤等種々の添加剤を併用できる。
In addition to known active ingredients, base agents such as surfactants and oils and fats, known moisturizers, antioxidants, ultraviolet rays, etc. may be added to the above-mentioned drugs, quasi-drugs and cosmetics. Various additives such as an absorbent / scattering agent, a chelating agent, a pH adjusting agent, a fragrance and a coloring agent can be used in combination.

【0039】[0039]

【実施例】次に実施例ならびにその効果を示すための試
験例を挙げるが、これらは本発明を何ら限定するもので
はない。
EXAMPLES Next, examples and test examples for showing the effects thereof will be shown, but these do not limit the present invention at all.

【0040】<試験例1> 活性酸素消去試験 本発明の皮膚外用剤のSOD活性 以下の処方例からなる化粧水基剤に、表1に示す有効成
分を配合し、McCordらの方法により、製剤中のSOD活
性を測定した。なお、本試験においては、原植物を10
gに溶媒100mlを加え、室温で3時間攪拌した後、
蒸発乾固した植物のエキスを用いた。また、処方例中、
精製水の配合割合(適量)は、全体で100重量%にな
る数値を意味する。
<Test Example 1> Active oxygen scavenging test SOD activity of the external preparation for skin of the present invention The active ingredient shown in Table 1 was added to a lotion base consisting of the following formulation examples, and a formulation was prepared by the method of McCord et al. The SOD activity in was measured. In this test, 10 plants were
After adding 100 ml of the solvent to g and stirring at room temperature for 3 hours,
Evaporated and dried plant extract was used. Also, in the prescription example,
The blending ratio (appropriate amount) of purified water means a numerical value of 100% by weight as a whole.

【0041】 (重量%) 1.ポリオキシエチレン硬化ヒマシ油(60E.0.) 8.00 2.エタノール 15.00 3.ベヘニルアルコール 1.00 4.パラオキシ安息香酸エステル 0.10 5.クエン酸 0.10 6.クエン酸ナトリウム 0.30 7.1,3−ブチレングリコール 4.00 8.エデト酸二ナトリウム 0.01 9.精製水 適 量(Wt%) 1. Polyoxyethylene hydrogenated castor oil (60E.0.) 8.00 2. Ethanol 15.00 3. Behenyl alcohol 1.00 4. Paraoxybenzoic acid ester 0.10 5. Citric acid 0.10 6. Sodium citrate 0.30 7.1,3-butylene glycol 4.00 8. Disodium edetate 0.01 9. Purified water Suitable amount

【0042】 [0042]

【0043】 [0043]

【0044】 [0044]

【0045】 [0045]

【0046】 [0046]

【0047】 [0047]

【0048】 [0048]

【0049】<試験例2> ハーフフェイス法によるシ
ワ改善効果試験 1)試験方法 エッセンス基剤(実施例7)に、表2に示した有効成分
を配合し、小ジワを有する女性(35ないし55才)に
朝晩の1日2回、顔面に連続塗布し、3ケ月後に小ジワ
の改善の程度を調べた。顔面の塗布は、ハーフ・フェイ
ス法で左右に行い、一方には有効成分を配合したエッセ
ンスを、他の一方側にはコントロールとして有効成分を
含まないもの(基剤のみ)を塗布し評価した。なお、本
試験においては、原植物を10gに溶媒100mlを加
え、室温で3時間攪拌した後、蒸発乾固した植物エキス
を用いた。
<Test Example 2> The half face method is used.
Wa improvement effect test 1) Test method The active ingredient shown in Table 2 was mixed with the essence base (Example 7), and a woman (35 to 55 years old) with small wrinkles was applied to the face twice a day in the morning and evening. After continuous application, the degree of improvement of small wrinkles was examined after 3 months. The face was applied to the left and right by the half-face method, and one side was coated with the essence containing the active ingredient, and the other side was coated with the essence containing no active ingredient (only the base) for evaluation. In this test, a plant extract was used in which 100 g of the solvent was added to 10 g of the original plant, the mixture was stirred at room temperature for 3 hours, and then evaporated to dryness.

【0050】2)試験結果 エッセンス使用前に対する小ジワの改善度を判定した結
果、本発明のエッセンスに明らかな子ジワ改善効果が認
められた。また、連続使用による皮膚異状は何ら認めら
れなかった。結果を表2に示す。
2) Test Results As a result of judging the degree of improvement of small wrinkles before the use of essence, the essence of the present invention was found to have a clear effect of reducing wrinkles. In addition, no skin abnormality was observed due to continuous use. The results are shown in Table 2.

【0051】 [0051]

【0052】 [0052]

【0053】[0053]

【処方例】以下に本発明の処方例を挙げる。なお、処方
例中、「適量」とは処方全体が100重量%になる量を
意味する。
[Prescription example] The prescription example of the present invention is given below. In the prescription examples, the “appropriate amount” means an amount that makes the entire prescription 100% by weight.

【0054】 <処方例1> クリーム (重量%) 1.モノステアリン酸ポリエチレングリコール(40E.0) 2.00 2.自己乳化型モノステアリン酸グリセリン 5.00 3. ステアリン酸 5.00 4.べへニルアルコール 1.00 5.流動パラフィン 10.00 6.トリオクタン酸グリセリル 10.00 7.パラオキシ安息香酸エステル 0.20 8.1,3−ブチレングリコール 5.00 9.エデト酸二ナトリウム 0.01 10.コウジ酸 1.00 11.アセンヤク(エタノールエキス) 0.50 12.アマチャ(水とエタノールの1:1混液エキス) 0.10 13.精製水 適 量 製造方法 A.1ないし6を加温、溶解する。 B.7ないし13を加温、溶解する。 C.AにBを加え乳化、攪拌し、冷却する。 D.Cを冷却後、容器に充填し、検査後製品とする。用法及び用量 適量に顔面に塗擦する。<Formulation Example 1> Cream (% by weight) 1. Polyethylene glycol monostearate (40E.0) 2.00 2. Self-emulsifying glyceryl monostearate 5.00 3. Stearic acid 5.00 4. Behenyl alcohol 1.00 5. Liquid paraffin 10.00 6. Glyceryl trioctanoate 10.00 7. Paraoxybenzoic acid ester 0.20 8.1,3-butylene glycol 5.00 9. Disodium edetate 0.01 10. Kojic acid 1.00 11. Acacia catechu (ethanol extract) 0.50 12. Amacha (1: 1 mixed extract of water and ethanol) 0.10 13. Purified water Proper amount Manufacturing method A. Heat 1 to 6 to dissolve. B. 7 to 13 are heated and dissolved. C. Add B to A, emulsify, stir, and cool. D. After C is cooled, it is filled in a container to be a product after inspection. How to use and dose Rub on face appropriately.

【0055】 <処方例2> 乳液 (重量%) 1.モノステアリン酸 ポリオキシエチレンソルビタン(20E.0.) 2.00 2.テトラオレイン酸 ポリオキシエチレンソルビット(60E.0.) 0.50 3.親油型モノステアリン酸グリセリン 1.00 4.ステアリン酸 0.50 5.べへニルアルコール 0.50 6.アボガド油 4.00 7.トリオクタン酸グリセリル 4.00 8.パラオキシ安息香酸エステル 0.20 9.1,3−ブチレングリコール 5.00 10.キサンタンガム 0.14 11.エデト酸二ナトリウム 0.01 12.コウジ酸 4.00 13.オウゴン(エタノールと1,3−ブチレングリコ ールの1:1混液エキス) 5.00 14.精製水 適 量製造方法 A.1ないし7を加温、溶解する。 B.8ないし14を加温、溶解する。 C.AにBを加え乳化、攪拌し、冷却する。 D.Cを冷却後、容器に充填し、検査後製品とした。用法及び用量 適量に顔面に塗擦する。<Formulation Example 2> Emulsion (wt%) 1. Monostearic acid Polyoxyethylene sorbitan (20E.0.) 2.00 2. Tetraoleic acid Polyoxyethylene sorbit (60E.0.) 0.50 3. 3. Lipophilic glyceryl monostearate 1.00 4. Stearic acid 0.50 5. Behenyl alcohol 0.50 6. Avocado oil 4.00 7. Glyceryl trioctanoate 4.00 8. Paraoxybenzoic acid ester 0.20 9.1,3-butylene glycol 5.00 10. Xanthan gum 0.14 11. Disodium edetate 0.01 12. Kojic acid 4.00 13. Ougon (1: 1 mixed liquid extract of ethanol and 1,3-butylene glycol) 5.00 14. Purified water Proper amount Manufacturing method A. Heat 1 to 7 to dissolve. B. Dissolve 8 to 14 by heating. C. Add B to A, emulsify, stir, and cool. D. After cooling C, it was filled in a container, and it was a product after inspection. How to use and dose Rub on face appropriately.

【0056】 <処方例3> 化粧水 (重量%) 1.ポリオキシエチレン硬化ヒマシ油(60E.0.) 8.00 2.エタノール 15.00 3.コウジ酸グルコシド 7.00 4.キナ(プロピレングリコールエキス) 2.00 5.キジムシロ(水エキス) 0.50 6.パラオキシ安息香酸エステル 0.10 7.クエン酸 0.10 8.クエン酸ナトリウム 0.30 9.1,3−ブチレングリコール 4.00 10.エデト酸二ナトリウム 0.01 11.精製水 適 量製造方法 A.1ないし11を均一に攪拌、溶解する。 B.Aを容器に充填し、検査後製品とする。用法及び用量 適量に顔面に塗擦する。<Prescription Example 3> Lotion (% by weight) 1. Polyoxyethylene hydrogenated castor oil (60E.0.) 8.00 2. Ethanol 15.00 3. Kojic acid glucoside 7.00 4. Quina (propylene glycol extract) 2.00 5. Kizimushiro (water extract) 0.50 6. Paraoxybenzoic acid ester 0.10 7. Citric acid 0.10 8. Sodium citrate 0.30 9.1,3-butylene glycol 4.00 10. Disodium edetate 0.01 11. Purified water Proper amount Manufacturing method A. 1 to 11 are uniformly stirred and dissolved. B. A is filled in a container and the product is obtained after the inspection. How to use and dose Rub on face appropriately.

【0057】 <処方例4> 軟膏剤 (重量%) 1.モノステアリン酸 ポリエチレングリコール(40E.0) 2.00 2.自己乳化型モノステアリン酸グリセリン 5.00 3.ステアリン酸 5.00 4.べへニルアルコール 1.00 5.流動パラフィン 10.00 6.トリオクタン酸グリセリル 10.00 7.パラオキシ安息香酸エステル 0.20 8.1,3−ブチレングリコール 5.00 9.エデト酸二ナトリウム 0.01 10.コウジ酸 1.00 11.キューカンバー(水エキス) 0.10 12.コローバー(エタノールエキス) 0.40 13.紅茶(エタノールエキス) 1.00 14.精製水 適 量 製造方法 A.1ないし6を加温、溶解する。 B.7ないし14を加温、溶解する。 C.AにBを加え乳化、攪拌し、冷却する。 D.Cを冷却後、容器に充填し、検査後製品とする。用法及び用量 適量に顔面に塗擦する。<Formulation Example 4> Ointment (wt%) 1. Polyethylene glycol monostearate (40E.0) 2.00 2. Self-emulsifying glyceryl monostearate 5.00 3. Stearic acid 5.00 4. Behenyl alcohol 1.00 5. Liquid paraffin 10.00 6. Glyceryl trioctanoate 10.00 7. Paraoxybenzoic acid ester 0.20 8.1,3-butylene glycol 5.00 9. Disodium edetate 0.01 10. Kojic acid 1.00 11. Cucumber (water extract) 0.10 12. Coro bar (ethanol extract) 0.40 13. Black tea (ethanol extract) 1.00 14. Purified water Proper amount Manufacturing method A. Heat 1 to 6 to dissolve. B. 7 to 14 are heated and dissolved. C. Add B to A, emulsify, stir, and cool. D. After C is cooled, it is filled in a container to be a product after inspection. How to use and dose Rub on face appropriately.

【0058】 <処方例5> パップ剤 (重量%) 1.ポリアクリル酸 30.00 2.コウジ酸 0.50 3.白樺幹スクラブ (水とエタノールの1:1混液エキス) 0.10 4.スイカ(エタノールエキス) 0.05 5.ステビア(水エキス) 0.05 6.ポリアクリル酸ソ−ダ 7.00 7.塩化アルミニウム 0.30 8.濃グリセリン 20.00 9.モノオレイン酸ソルビタン 1.00 10.酸化チタン 4.00 11.精製水 適量 製造方法 A.1ないし5,9及び11を加温,溶解する。 B.6ないし8及び10を加温、溶解する。 C.AにBを加え均一に攪拌し、混合する。 D.Cを冷却後、塗布剤に塗布し、検査後製品とした。用法及び用量 ライナ−を剥離し、患部に塗布する。<Formulation Example 5> Pap agent (% by weight) 1. Polyacrylic acid 30.00 2. Kojic acid 0.50 3. Shirakaba trunk scrub (1: 1 mixed liquid extract of water and ethanol) 0.10 4. Watermelon (ethanol extract) 0.05 5. Stevia (water extract) 0.05 6. Polyacrylic acid soda 7.00 7. Aluminum chloride 0.30 8. Concentrated glycerin 20.00 9. Sorbitan monooleate 1.00 10. Titanium oxide 4.00 11. Purified water Suitable amount manufacturing method A. 1 to 5, 9 and 11 are heated and dissolved. B. Heat 6 to 8 and 10 to dissolve. C. Add B to A, stir evenly, and mix. D. After cooling C, it was applied to a coating agent, and after inspection, a product was obtained. Usage and dose: Remove the liner and apply to the affected area.

【0059】 <処方例6> 浴用剤 (重量%) 1.流動パラフィン 65.00 2.ジー2−ヘプチルウンデカン酸 グリセリンモノステアレート 5.00 3.ポリオキシエチレン(2E.0.)グリセリン モノステアレート 2.00 4.ポリオキシエチレン(9E.0.) モノオレート 2.00 5.ポリオキシエチレン(3E.0.) ラウリルエーテル 5.00 6.ビタミンE 0.20 7.コウジ酸モノパルミテート 2.00 8.セイヨウキズタ(プロピレングリコールと水の 1:1混液エキス) 3.00 9.香料 1.00 10.色素 微 量 11.エタノール 適 量製造方法 A.1ないし9を混合溶解する。 B.11に10を添加し、溶解する。 C.AにBを加え均一に攪拌する。 D.Cを軟カプセルに充填し、検査後製品とした。用法及び用量 適量を浴槽に入れ入浴する。<Formulation Example 6> Bath agent (% by weight) 1. Liquid paraffin 65.00 2. Di-2-heptyl undecanoic acid Glycerin monostearate 5.00 3. Polyoxyethylene (2E.0.) Glycerin monostearate 2.00 4. Polyoxyethylene (9E.0.) Monooleate 2.00 5. Polyoxyethylene (3E.0.) Lauryl ether 5.00 6. Vitamin E 0.20 7. Kojic acid monopalmitate 2.00 8. Prickly pear (1: 1 mixed extract of propylene glycol and water) 3.00 9. Fragrance 1.00 10. Minute amount of dye 11. Ethanol Proper amount production method A. Mix and dissolve 1 to 9. B. Add 10 to 11 and dissolve. C. Add B to A and stir uniformly. D. C was filled in a soft capsule, and a product was obtained after the inspection. Dosage and dosage Put an appropriate amount in the bath and take a bath.

【0060】 <処方例7> エッセンス (重量%) 1.1%カルボキシビニルポリマー溶液 10.00 2.グリセリン 20.00 3.ヒアルロン酸 0.50 4.エタノール 7.00 5.コウジ酸ガラクトミド 3.00 6.コウジ酸 2.00 7.タチジャコソウ(水エキス) 1.00 8.チョウジ(水エキス) 0.20 9.月見草(エタノールエキス) 0.10 10.ナナカマド(水エキス) 0.01 11.バナナ(エタノールエキス) 0.01 12.精製水 適 量 製造方法 上記の各成分を混合、均一に攪拌、溶解しエッセンスを
製造した。用法及び用量 適量顔面に塗擦する。処方例1ないし7の皮膚外用剤
は、いずれも本発明の目的を満足する効果を有する製剤
であることが確認された。
<Formulation Example 7> Essence (% by weight) 1.1% carboxyvinyl polymer solution 10.00 2. Glycerin 20.00 3. Hyaluronic acid 0.50 4. Ethanol 7.00 5. Galactimide kojic acid 3.00 6. Kojic acid 2.00 7. Tachijakoso (water extract) 1.00 8. Clove (water extract) 0.20 9. Evening primrose (ethanol extract) 0.10 10. Rowan (water extract) 0.01 11. Banana (ethanol extract) 0.01 12. Purified water Appropriate amount Production method The above components were mixed, uniformly stirred, and dissolved to produce essence. Usage and dose Appropriate amount Rub on face. It was confirmed that each of the external preparations for skin of Formulation Examples 1 to 7 is a preparation having an effect satisfying the object of the present invention.

【0061】[0061]

【発明の効果】本発明によれば、コウジ酸及び/又はそ
の誘導体と特定の植物エキスを有効成分として含有する
ことを特徴とする新規な皮膚外用剤が提供され、この外
用剤は皮膚に対する安全性が高く、日焼けによる傷んだ
肌の改善が極めて効果的にでき、小じわなどの皮膚の老
化を防止することができる。
Industrial Applicability According to the present invention, there is provided a novel skin preparation for external use, which comprises kojic acid and / or a derivative thereof and a specific plant extract as active ingredients. It is highly effective and can very effectively improve damaged skin due to sunburn, and can prevent skin aging such as fine wrinkles.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 コウジ酸及び/又はその誘導体と、アセ
ンヤク、アマチャ、オウゴン、キナ、キジムシロ、キュ
ーカンバー、クローバー、紅茶、白樺幹スクラブ、スイ
カ、ステビア、セイヨウキズタ、タチジャコソウ、チョ
ウジ、月見草、ナナカマド、バナナ、ヒキオコシ、ヘイ
フラワー、マーシュティー、マテ、メロン、リンゴ、ラ
ベンダー、レモンからなる群より選ばれた植物のエキス
の一種又は二種以上を有効成分として含有することを特
徴とする皮膚外用剤。
1. Kojic acid and / or a derivative thereof, and Acenyak, Amacha, Ougon, Kina, Kijimushiro, Cucumber, Clover, Black tea, Birch trunk scrub, Watermelon, Stevia, Ivy, Ivy, Periwinkle, Evening grass, Rowan, Banana An external preparation for skin, which comprises, as an active ingredient, one or more kinds of plant extracts selected from the group consisting of Hikioko, Hayflower, Marsh tea, mate, melon, apple, lavender, and lemon.
JP16251593A 1993-06-30 1993-06-30 External preparation for skin Expired - Lifetime JP3529811B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16251593A JP3529811B2 (en) 1993-06-30 1993-06-30 External preparation for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16251593A JP3529811B2 (en) 1993-06-30 1993-06-30 External preparation for skin

Publications (2)

Publication Number Publication Date
JPH0717847A true JPH0717847A (en) 1995-01-20
JP3529811B2 JP3529811B2 (en) 2004-05-24

Family

ID=15756094

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16251593A Expired - Lifetime JP3529811B2 (en) 1993-06-30 1993-06-30 External preparation for skin

Country Status (1)

Country Link
JP (1) JP3529811B2 (en)

Cited By (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH092941A (en) * 1995-06-19 1997-01-07 Tsumura & Co Bath medicine composition and its use
JPH0977636A (en) * 1995-09-14 1997-03-25 Mikimoto Pharmaceut Co Ltd Beautifying and whitening cosmetic
JPH09165313A (en) * 1995-12-15 1997-06-24 Kao Corp Skin preparation for external use
WO1997030680A1 (en) * 1996-02-22 1997-08-28 Wella Aktiengesellschaft Cosmetic agent with an ilex resin content, process for extraction of ilex resin and ilex resin obtained thereby
JPH09255519A (en) * 1996-03-19 1997-09-30 Noevir Co Ltd Antibacterial low irritating cosmetic material
JPH09291011A (en) * 1996-04-24 1997-11-11 Kose Corp Composition suitable for eternal use
WO1998019687A1 (en) * 1996-11-07 1998-05-14 Jong Hyun Nam Natural teas for taking off the effects of drink and process for the production thereof
JPH10182414A (en) * 1996-12-27 1998-07-07 Shiseido Co Ltd Antiaging agent
FR2769502A1 (en) * 1997-10-14 1999-04-16 Sederma Sa Cosmetic and dermopharmaceutical compositions containing a trefoil extract to counteract the dermal effects of the menopause
WO1999047006A1 (en) * 1998-03-19 1999-09-23 Sunstar Inc. Foods, medical treatments and method relating to effects of promoting the growth of lactobacillus bifidus, preventing allergy and lowering human cholesterol level
JPH11279069A (en) * 1998-03-27 1999-10-12 Ichimaru Pharcos Co Ltd Active oxygen eliminating agent
EP0956859A1 (en) * 1996-09-27 1999-11-17 Takeshi Karita Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same
JP2001064192A (en) * 1999-08-25 2001-03-13 Sunstar Inc Migration inhibitor for langerhans cell and antigen presentation inhibitor
EP1049451A4 (en) * 1997-12-24 2001-04-11 Novogen Res Pty Ltd Compositions and method for protecting skin from uv induced immunosuppression and skin damage
JP2002029988A (en) * 2000-07-19 2002-01-29 Pola Chem Ind Inc Corium collagen fiber bundle-restructuring agent and composition containing the same
JP2002308752A (en) * 2001-04-06 2002-10-23 Nikko Chemical Co Ltd Skin care preparation
KR20030005078A (en) * 2002-10-22 2003-01-15 최재수 The toilet lotion and the manufacture process of the toilet lotion
KR100369578B1 (en) * 1998-03-20 2003-03-17 주식회사 태평양 Cosmetics containing natural herb extract having wrinkle-curing activity
JP2003171225A (en) * 2001-11-30 2003-06-17 Fancl Corp COMPOSITION FOR INTEGRINalpha6beta4 PRODUCTION PROMOTION
JP2003226655A (en) * 2002-01-31 2003-08-12 Fancl Corp COMPOSITION CONTAINING LAMININ-5 PRODUCTION PROMOTER AND INTEGRIN-alpha6beta4 PRODUCTION PROMOTER
WO2004000836A1 (en) * 2002-06-22 2003-12-31 Amorepacific Corporation Hydroxy pyranone derivative and preparation method thereof
JP2007505034A (en) * 2003-07-30 2007-03-08 セバグ、ジャン・ルイ Composition containing melon extract
JP2007077171A (en) * 2006-12-25 2007-03-29 Kao Corp Cathepsin d production promoter
JP2007254344A (en) * 2006-03-23 2007-10-04 Naris Cosmetics Co Ltd Maillard reaction inhibitor, skin care preparation containing the same and food and beverage
US7514469B2 (en) 2002-04-30 2009-04-07 Unigen Pharmaceuticals, Inc. Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent
JP2009073777A (en) * 2007-09-21 2009-04-09 Kao Corp Cosmetic
JP2009108104A (en) * 2002-11-19 2009-05-21 Basf Beauty Care Solutions France Sas Test method of activity of substance which may be effective in inhibiting enzyme activity of phospholipase a2
US7695743B2 (en) 2002-04-30 2010-04-13 Unigen Pharmaceuticals, Inc. Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
JP2010254667A (en) * 2009-03-31 2010-11-11 Fancl Corp Collagen gel shrinking agent
JP2011032219A (en) * 2009-08-03 2011-02-17 Fancl Corp Agent for contracting collagen gel
JP2011157281A (en) * 2010-01-29 2011-08-18 Fancl Corp Collagen gel-shrinking agent
JP2011219454A (en) * 2010-03-24 2011-11-04 Fancl Corp Intercellular adhesive
US8247007B2 (en) 2006-10-12 2012-08-21 Unigen, Inc. Composition for treating atopic dermatitis comprising extracts of bamboo and Scutellaria
WO2012116992A3 (en) * 2011-03-01 2013-01-10 Dsm Ip Assets B.V. Oral use of a composition comprising steviol or isosteviol
WO2013093881A1 (en) * 2011-12-23 2013-06-27 L'oreal Cosmetic use of steviol, of a steviol glycoside derivative or of one of their isomers to stimulate, restore or regulate the metabolism of the cells of the skin and semimucus membranes
JP2014506595A (en) * 2011-02-22 2014-03-17 アクゾ ノーベル ケミカルズ インターナショナル ベスローテン フエンノートシャップ A composition containing a serum fraction of Bengal bodyfish, lotus and clover (aging)
US8945518B2 (en) 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US9061039B2 (en) 2002-03-01 2015-06-23 Unigen, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US9168242B2 (en) 2002-03-22 2015-10-27 Unigen, Inc. Isolation of a dual COX-2 and 5-lipdxygenase inhibitor from Acacia
CN105585471A (en) * 2016-01-18 2016-05-18 大连理工大学 Extraction method of active ingredients of isodon amethystoides
US9622964B2 (en) 2003-04-04 2017-04-18 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2889949B1 (en) * 2005-08-26 2014-01-10 Jean Noel Thorel USE OF A COSMETIC AND / OR DERMOCOSMETIC ACTIVE BASE WITH PLANT PYRUS MALUS EXTRACT
JP2012031133A (en) * 2010-06-30 2012-02-16 Fancl Corp Proteasome activator

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57209209A (en) * 1981-02-27 1982-12-22 Oreal Hair and skin treatment cosmetic composition
JPS6225190A (en) * 1985-04-24 1987-02-03 バ−・イラン・ユニバ−シテイ− Oxidation inhibitor composition and its use
JPS6483013A (en) * 1987-09-24 1989-03-28 Narisu Cosmetic Co Ltd Dermal drug for external use
JPS6483010A (en) * 1987-09-25 1989-03-28 Sansho Seiyaku Kk Melanization inhibitory drug for external use
JPH02243632A (en) * 1989-03-16 1990-09-27 Ichimaru Pharcos Co Ltd Peroxide lipid formation inhibitor comprising vegetable oil extract
JPH03200708A (en) * 1989-12-28 1991-09-02 Max Fuakutaa Kk Dermal external agent
JPH03236322A (en) * 1990-02-13 1991-10-22 Kobayashi Kose Co Ltd Skin drug for external use
JPH05139950A (en) * 1991-11-26 1993-06-08 Pola Chem Ind Inc Cosmetic

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57209209A (en) * 1981-02-27 1982-12-22 Oreal Hair and skin treatment cosmetic composition
JPS6225190A (en) * 1985-04-24 1987-02-03 バ−・イラン・ユニバ−シテイ− Oxidation inhibitor composition and its use
JPS6483013A (en) * 1987-09-24 1989-03-28 Narisu Cosmetic Co Ltd Dermal drug for external use
JPS6483010A (en) * 1987-09-25 1989-03-28 Sansho Seiyaku Kk Melanization inhibitory drug for external use
JPH02243632A (en) * 1989-03-16 1990-09-27 Ichimaru Pharcos Co Ltd Peroxide lipid formation inhibitor comprising vegetable oil extract
JPH03200708A (en) * 1989-12-28 1991-09-02 Max Fuakutaa Kk Dermal external agent
JPH03236322A (en) * 1990-02-13 1991-10-22 Kobayashi Kose Co Ltd Skin drug for external use
JPH05139950A (en) * 1991-11-26 1993-06-08 Pola Chem Ind Inc Cosmetic

Cited By (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH092941A (en) * 1995-06-19 1997-01-07 Tsumura & Co Bath medicine composition and its use
JPH0977636A (en) * 1995-09-14 1997-03-25 Mikimoto Pharmaceut Co Ltd Beautifying and whitening cosmetic
JPH09165313A (en) * 1995-12-15 1997-06-24 Kao Corp Skin preparation for external use
WO1997030680A1 (en) * 1996-02-22 1997-08-28 Wella Aktiengesellschaft Cosmetic agent with an ilex resin content, process for extraction of ilex resin and ilex resin obtained thereby
JPH09255519A (en) * 1996-03-19 1997-09-30 Noevir Co Ltd Antibacterial low irritating cosmetic material
JPH09291011A (en) * 1996-04-24 1997-11-11 Kose Corp Composition suitable for eternal use
EP0956859A1 (en) * 1996-09-27 1999-11-17 Takeshi Karita Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same
EP0956859A4 (en) * 1996-09-27 2003-04-16 Takeshi Karita Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same
WO1998019687A1 (en) * 1996-11-07 1998-05-14 Jong Hyun Nam Natural teas for taking off the effects of drink and process for the production thereof
US5968520A (en) * 1996-11-07 1999-10-19 Nam; Jong Hyun Natural teas for taking off the effects of drink and process for the production thereof
WO1998029093A1 (en) * 1996-12-27 1998-07-09 Shiseido Company, Ltd. Antiaging agent
JPH10182414A (en) * 1996-12-27 1998-07-07 Shiseido Co Ltd Antiaging agent
FR2769502A1 (en) * 1997-10-14 1999-04-16 Sederma Sa Cosmetic and dermopharmaceutical compositions containing a trefoil extract to counteract the dermal effects of the menopause
WO1999018927A1 (en) * 1997-10-14 1999-04-22 Sederma S.A. Compositions for cosmetic and dermopharmaceutical use containing a plant extract obtained from clover (trifolium sp.)
EP1049451A4 (en) * 1997-12-24 2001-04-11 Novogen Res Pty Ltd Compositions and method for protecting skin from uv induced immunosuppression and skin damage
WO1999047006A1 (en) * 1998-03-19 1999-09-23 Sunstar Inc. Foods, medical treatments and method relating to effects of promoting the growth of lactobacillus bifidus, preventing allergy and lowering human cholesterol level
KR100369578B1 (en) * 1998-03-20 2003-03-17 주식회사 태평양 Cosmetics containing natural herb extract having wrinkle-curing activity
JPH11279069A (en) * 1998-03-27 1999-10-12 Ichimaru Pharcos Co Ltd Active oxygen eliminating agent
JP2001064192A (en) * 1999-08-25 2001-03-13 Sunstar Inc Migration inhibitor for langerhans cell and antigen presentation inhibitor
JP2002029988A (en) * 2000-07-19 2002-01-29 Pola Chem Ind Inc Corium collagen fiber bundle-restructuring agent and composition containing the same
JP2002308752A (en) * 2001-04-06 2002-10-23 Nikko Chemical Co Ltd Skin care preparation
JP2003171225A (en) * 2001-11-30 2003-06-17 Fancl Corp COMPOSITION FOR INTEGRINalpha6beta4 PRODUCTION PROMOTION
JP2003226655A (en) * 2002-01-31 2003-08-12 Fancl Corp COMPOSITION CONTAINING LAMININ-5 PRODUCTION PROMOTER AND INTEGRIN-alpha6beta4 PRODUCTION PROMOTER
US9061039B2 (en) 2002-03-01 2015-06-23 Unigen, Inc. Identification of Free-B-Ring flavonoids as potent COX-2 inhibitors
US9168242B2 (en) 2002-03-22 2015-10-27 Unigen, Inc. Isolation of a dual COX-2 and 5-lipdxygenase inhibitor from Acacia
US9849152B2 (en) 2002-04-30 2017-12-26 Unigen, Inc. Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent
US9655940B2 (en) 2002-04-30 2017-05-23 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
US9370544B2 (en) 2002-04-30 2016-06-21 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
US7695743B2 (en) 2002-04-30 2010-04-13 Unigen Pharmaceuticals, Inc. Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
US7514469B2 (en) 2002-04-30 2009-04-07 Unigen Pharmaceuticals, Inc. Formulation of a mixture of Free-B-ring flavonoids and flavans as a therapeutic agent
US8945518B2 (en) 2002-04-30 2015-02-03 Unigen, Inc. Formulation of dual eicosanoid system and cytokine system inhibitors for use in the prevention and treatment of oral diseases and conditions
US8034387B2 (en) * 2002-04-30 2011-10-11 Unigen, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
EP2108370A1 (en) 2002-04-30 2009-10-14 Unigen Pharmaceuticals, Inc. Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent
CN1310910C (en) * 2002-06-22 2007-04-18 株式会社太平洋 Hydroxy pyranone derivative and preparation method thereof
WO2004000836A1 (en) * 2002-06-22 2003-12-31 Amorepacific Corporation Hydroxy pyranone derivative and preparation method thereof
KR20030005078A (en) * 2002-10-22 2003-01-15 최재수 The toilet lotion and the manufacture process of the toilet lotion
JP2012224637A (en) * 2002-11-19 2012-11-15 Basf Beauty Care Solutions France Sas Method of testing activity of potentially active substance to inhibit enzymatic activity of phospholipase a2
JP2009108104A (en) * 2002-11-19 2009-05-21 Basf Beauty Care Solutions France Sas Test method of activity of substance which may be effective in inhibiting enzyme activity of phospholipase a2
US9622964B2 (en) 2003-04-04 2017-04-18 Unigen, Inc. Formulation of dual cycloxygenase (COX) and lipoxygenase (LOX) inhibitors for mammal skin care
JP2007505034A (en) * 2003-07-30 2007-03-08 セバグ、ジャン・ルイ Composition containing melon extract
JP2007254344A (en) * 2006-03-23 2007-10-04 Naris Cosmetics Co Ltd Maillard reaction inhibitor, skin care preparation containing the same and food and beverage
US8771761B2 (en) 2006-10-12 2014-07-08 Unigen, Inc. Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria
US9623068B2 (en) 2006-10-12 2017-04-18 Unigen, Inc. Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria
US8247007B2 (en) 2006-10-12 2012-08-21 Unigen, Inc. Composition for treating atopic dermatitis comprising extracts of bamboo and Scutellaria
JP2007077171A (en) * 2006-12-25 2007-03-29 Kao Corp Cathepsin d production promoter
JP2009073777A (en) * 2007-09-21 2009-04-09 Kao Corp Cosmetic
JP2010254667A (en) * 2009-03-31 2010-11-11 Fancl Corp Collagen gel shrinking agent
JP2011032219A (en) * 2009-08-03 2011-02-17 Fancl Corp Agent for contracting collagen gel
JP2011157281A (en) * 2010-01-29 2011-08-18 Fancl Corp Collagen gel-shrinking agent
JP2011219454A (en) * 2010-03-24 2011-11-04 Fancl Corp Intercellular adhesive
JP2014506595A (en) * 2011-02-22 2014-03-17 アクゾ ノーベル ケミカルズ インターナショナル ベスローテン フエンノートシャップ A composition containing a serum fraction of Bengal bodyfish, lotus and clover (aging)
US9993508B2 (en) 2011-02-22 2018-06-12 Isp Investments Llp Composition comprising banyan tree, lotus, and clover serum fractions (aging)
WO2012116992A3 (en) * 2011-03-01 2013-01-10 Dsm Ip Assets B.V. Oral use of a composition comprising steviol or isosteviol
CN104125822A (en) * 2011-12-23 2014-10-29 欧莱雅 Cosmetic use of steviol, of steviol glycoside derivative or of one of their isomers to stimulate, restore or regulate metabolism of cells of the skin and semimucus membranes
FR2984743A1 (en) * 2011-12-23 2013-06-28 Oreal COSMETIC USE OF STEVIOL, STEVIOL GLYCOSIDE DERIVATIVE, OR ONE OF THEIR ISOMERS FOR STIMULATING, RESTORING OR REGULATING METABOLISM OF SKIN CELLS AND SEMI-MUCOUS MEMBRANES
WO2013093881A1 (en) * 2011-12-23 2013-06-27 L'oreal Cosmetic use of steviol, of a steviol glycoside derivative or of one of their isomers to stimulate, restore or regulate the metabolism of the cells of the skin and semimucus membranes
US9687434B2 (en) 2011-12-23 2017-06-27 L'oreal Cosmetic use of steviol, of a steviol glycoside derivative or of one of their isomers to stimulate, restore or regulate the metabolism of the cells of the skin and semimucus membranes
CN105585471A (en) * 2016-01-18 2016-05-18 大连理工大学 Extraction method of active ingredients of isodon amethystoides

Also Published As

Publication number Publication date
JP3529811B2 (en) 2004-05-24

Similar Documents

Publication Publication Date Title
JP3529811B2 (en) External preparation for skin
JP3415197B2 (en) External preparation for skin
JP3415199B2 (en) External preparation for skin
JP3415198B2 (en) External preparation for skin
KR101566320B1 (en) Cosmetic composition comprising an Impatiens balsamina L, Maca, Rosa multiflora Thunberg, Eryobotrya japonica and Pachyrrhizus erosus Complex-fermented extract
JP5137457B2 (en) Stem cell growth factor expression increase inhibitor
JP3407935B2 (en) External preparation for skin
KR102113645B1 (en) A cosmetic composition for preventing hair loss and promoting hair growth containing spicule powder and natural extract
KR100753186B1 (en) A anti-aging cosmetic composition containing a herb extracts mixture
KR101397160B1 (en) Cosmetic compositon for skin-irritation alleviation with Inula britannica var. chinensis, Cynanchi Radix and Lysimachia foenum-graecum Hance
JPH0717848A (en) Skin external preparation
KR102004366B1 (en) A cosmetic composition comprising centipeda minima extract
Mamillapalli et al. Formulation, phytochemical, physical, biological evaluation of polyherbal vanishing cream, and facewash
KR20140145278A (en) Cosmetic composition containing Cimicifuga heracleifolia extract, Cornus officinalis extract and Geranium nepalense extract for skin convergence and elasticity effect
KR102025859B1 (en) Cosmetic or phamaceutical composition comprising herb extract and method for preparing the same
KR20090105225A (en) The cosmetic composition for preventing the skin aging
KR102177613B1 (en) Cosmetic composition for slimming comprising complex extracts of Taraxacum platycarpum, Lonicera japonica and Perilla frutescens
KR101941691B1 (en) Cosmetic herbal essence composition having excellent of antioxidant effect and skin improvement and a method for preparing it
KR100946690B1 (en) Cosmetic composition with anti inflammation effect containing fermented extract of organic tomato, Prunus mume Sieb.Et Zucc, unshui citrus, peach and aloe
KR102504878B1 (en) cosmetic composition having anti-inflammatory and skin soothing and effects and improvement of skin itching containing fermented extracts of Campsis grandiflora, Plum blossom, Quercus acuta THUNB
KR102289943B1 (en) Cosmetic composition containing complex extracts of Chrysanthemum Sibiricum, Viscum Album, Selaginella Tamariscina, Portulaca Oleracea and Perilla Frutescens
KR100433055B1 (en) Cosmetic composition for cutis elastica or skin-moisture containing Trichosanthes kirilowii
KR102208482B1 (en) Cosmetic composition for improving skin troubles
KR102314004B1 (en) Antibacterial and highly moisturizing cleansing oil containing Euphorbia humifusa extract and method for manufacturing same
KR102446610B1 (en) Cleansing composition having increased scopolin, scopoletin and ginsenosides and its use

Legal Events

Date Code Title Description
A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20030318

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040224

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040226

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090305

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100305

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110305

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120305

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120305

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130305

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140305

Year of fee payment: 10

EXPY Cancellation because of completion of term